Last updated: March 16, 2022
Sponsor: Hospital Clinic of Barcelona
Overall Status: Active - Recruiting
Phase
N/A
Condition
Precancerous Condition
Colorectal Cancer
Colon Cancer
Treatment
N/AClinical Study ID
NCT04909671
Timely
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age ≥18 years with a proven pathogenic germline variant in one of the MMR genes (MLH1,MSH2, MSH6) or Epcam deletion who are under surveillance colonoscopy.
Exclusion
Exclusion Criteria:
- Previous history of total colectomy,
- Concomitant inflammatory bowel disease,
- Inability or refuse to sign the informed consent,
- Previous colonoscopy < 12 months.
- Inadequate bowel preparation.
- Incomplete procedure.
- PMS2 mutation carriers
Study Design
Total Participants: 404
Study Start date:
September 13, 2021
Estimated Completion Date:
December 01, 2023
Study Description
Connect with a study center
María Pellisé. MD. PhD.
Barcelona, 08036
SpainActive - Recruiting
Oswaldo ortiz
Barcelona, 08036
SpainActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.